Table 1.
Lipoprotein lipid composition assessed by 1H-NMR
(mg/dL) | Women | Men | P-Value |
VLDLc | 12.5 [7.3–17.7] | 16.7 [11.4–24.4] | 0.002 |
VLDLtg | 47.9 [34.9–75.1] | 72.6 [51.1–101.0] | 0.000 |
IDLc | 8.5 [6.4–13.3] | 10.2 [7.6–11.7] | 0.352 |
IDLtg | 9.3 [7.8–12.5] | 10.4 [9.0-11.4] | 0.443 |
LDLc | 124.3 [116.2-149.8] | 135.4 [120.3-152.1] | 0.207 |
LDLtg | 13.0 [11.1–16.4] | 13.9 [11.6–16.1] | 0.532 |
HDLc | 58.9 [54.9–65.1] | 54.0 [49.6–57.8] | 0.000 |
HDLtg | 14.7 [11.2–16.6] | 13.5 [10.9–16.0] | 0.254 |
(mg/dL) | Overweight | Obese | P-Value |
VLDLc | 12.7 [8.0–20.0] | 16.0 [11.8–22.3] | 0.052 |
VLDLtg | 50.7 [37.0-88.6] | 70.3 [50.1–94.2] | 0.024 |
IDLc | 8.7 [6.4–11.3] | 10.7 [7.1–12.8] | 0.080 |
IDLtg | 9.7 [7.6–11.4] | 10.4 [8.7–12.2] | 0.052 |
LDLc | 133.8 [116.2-147.2] | 132.3 [119.5-154.6] | 0.357 |
LDLtg | 13.4 [11.3–16.3] | 13.9 [11.4–17.3] | 0.198 |
HDLc | 56.4 [51.6–64.4] | 55.9 [53.2–60.9] | 0.623 |
HDLtg | 13.5 [10.7–16.1] | 14.9 [12.1–16.5] | 0.193 |
Values are shown as median [IQR]. Lipoprotein cholesterol and triglycerides are expressed as mg/dL. P-Value: Wilcoxon Mann Whitney-test. Boldface indicates statistical significance (P < 0.05). 1H-NMR: Proton nuclear magnetic resonance; Very low-, low-, intermediate- and high- density lipoprotein (VLDL, LDL, IDL and HDL, respectively). c: Cholesterol; tg: Triglycerides